Ann: Quarterly activities report and cashflow, page-15

Personally i have very little concerns with regards to the companies fundamentals and cash reserves.
Also quite happy to have another dig at the options at these ridiculously cheap prices.

Well over 12 months to expirations.
Patient to give the options another 12 months and 4 more quarterly reports to show increasing Revenues.

-Axim deal done.

-4 trials successfully initiated

-Futher distribution deals announced.

-Mouth guard sales increasing.

& Very important .... the back end option deals on successful completion of very achievable
milestones/results.

Each to their own...